On the contrary, acquired CcO deficiency, which has previously been ascribed to the accumulation of mtDNA defects over time and the subsequent ETC disruption, may be central in the pathogenesis of a nonalcoholic fatty liver disease (Paradies et al, 2014). The gene discussed is RYR1; the disease is metabolic dysfunction-associated steatotic liver disease.